Citation Impact
Citing Papers
Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c- MYC transcription
2002 Standout
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Mechanisms of action of tasquinimod on the tumour microenvironment
2013
HER2 Specific Tumor Targeting with Dendrimer Conjugated Anti-HER2 mAb
2006
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Finishing the euchromatic sequence of the human genome
2004 StandoutNature
Are there generic mechanisms governing interactions between nanoparticles and cells? Epitope mapping the outer layer of the protein–material interface
2006
EGFR Antagonists in Cancer Treatment
2008 Standout
Therapeutic and diagnostic applications of dendrimers for cancer treatment☆
2008
Chimerism of the Transplanted Heart
2002 Standout
Acromegaly
2006 Standout
Boron Neutron Capture Therapy of Brain Tumors: Past History, Current Status, and Future Potential
1996
IDH1andIDH2Mutations in Gliomas
2009 Standout
Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria
2001
Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor
2004 StandoutNobel
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
2007
Genetic Pathways to Primary and Secondary Glioblastoma
2007
Somatostatin Analogues for Receptor Targeted Photodynamic Therapy
2014
Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶
2004
Structure of the active core of human stem cell factor and analysis of binding to its receptor Kit
2000
Differentiation of trophoblast endocrine cells
1996
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Clinical and magnetic resonance imaging manifestations of neurosarcoidosis
2005
Significance of “Abnormal” Nadir Growth Hormone Levels after Oral Glucose in Postoperative Patients with Acromegaly in Remission with Normal Insulin-Like Growth Factor-I Levels
2004
Dendritic Polymers in Biomedical Applications: From Potential to Clinical Use in Diagnostics and Therapy
2002
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy
2016
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation
2012
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles
2014
Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles
2011
Nature: A rich source for developing multifunctional agents. tumor‐imaging and photodynamic therapy
2006
Dendrimer biocompatibility and toxicity
2005
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Graft-versus-host disease
2009 Standout
Epidemiology of Brain Tumors
2007
Dendrimers and dendritic polymers in drug delivery
2005
Malignant Gliomas in Adults
2008 Standout
Migraine — Current Understanding and Treatment
2002 Standout
Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex
2005
Efficacy and Safety of Acetaminophen, Aspirin, and Caffeine in Alleviating Migraine Headache Pain
1998
Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer
2008
Efficiency and Fidelity in a Click‐Chemistry Route to Triazole Dendrimers by the Copper(I )‐Catalyzed Ligation of Azides and Alkynes
2004 StandoutNobel
Nanomaterials: Applications in Cancer Imaging and Therapy
2011
Dendrimers as versatile platform in drug delivery applications
2008
HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb
2008
The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs
2008
Targeting cancer cells with biotin–dendrimer conjugates
2008
Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery
2008
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
2007
Peptide dendrimers
2005
Chorionic Gonadotropin Has a Recent Origin Within Primates and an Evolutionary History of Selection
2002
Human NM23/Nucleoside Diphosphate Kinase Regulates Gene Expression through DNA Binding to Nuclease-Hypersensitive Transcriptional Elements
2000
Multivalent Dendrons for High‐Affinity Adhesion of Proteins to DNA
2006
Sarcoidosis
2007 Standout
Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors
1996
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Mechanisms for oncogenic activation of the epidermal growth factor receptor
2007
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
1998 Standout
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
2007 Standout
The Golden Age of Transfer Hydrogenation
2015 Standout
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
2001
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Highly Selective Synthesis of the Ring-B Reduced Chlorins by Ferric Chloride-Mediated Oxidation of Bacteriochlorins: Effects of the Fused Imide vs Isocyclic Ring on Photophysical and Electrochemical Properties
2008
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Conjugation of 2-(1′-Hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to Carbohydrates Changes its Subcellular Distribution and Enhances Photodynamic Activity in Vivo
2009
State of the Art and Prospects in Metal–Organic Framework (MOF)-Based and MOF-Derived Nanocatalysis
2019 Standout
Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
2005
Combinatorial patterns of somatic gene mutations in cancer
2008
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier.
1999
Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
1997
Dendrimers Containing Heteroatoms (Si, P, B, Ge, or Bi)
1999
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
NM23-H1 and NM23-H2 Repress Transcriptional Activities of Nuclease-hypersensitive Elements in the Platelet-derived Growth Factor-A Promoter
2002
The effect of particle design on cellular internalization pathways
2008 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Tumour and dendrimers: a review on drug delivery aspects
2008
Nanoparticles in Photodynamic Therapy
2015 Standout
Boron-Containing Polyamines as DNA Targeting Agents for Neutron Capture Therapy of Brain Tumors: Synthesis and Biological Evaluation
1997
Management of Venous Thromboembolism in Patients With Primary and Metastatic Brain Tumors
2006
Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability
2009 StandoutNobel
A First Comparative Study of Purpurinimide-based Fluorinated vs. Nonfluorinated Photosensitizers for Photodynamic Therapy¶
2002
Targeted delivery of methotrexate to epidermal growth factor receptor–positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates
2006
Epidermal Growth Factor Radiopharmaceuticals: 111In Chelation, Conjugation to a Blood-Brain Barrier Delivery Vector via a Biotin-Polyethylene Linker, Pharacokinetics, and in Vivo Imaging of Experimental Brain Tumors
1999
Dendrimers as Drugs: Discovery and Preclinical and Clinical Development of Dendrimer-Based Microbicides for HIV and STI Prevention
2005
Bioinspired application of dendrimers: From bio-mimicry to biomedical applications
2008
Antibody−Dendrimer Conjugates: The Number, Not the Size of the Dendrimers, Determines the Immunoreactivity
2008
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
2005
Receptor‐Mediated Uptake of Boron‐Rich Neuropeptide Y Analogues for Boron Neutron Capture Therapy
2014
New photosensitizers for photodynamic therapy
2016 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Cancer Genome Landscapes
2013 StandoutScience
Magnetically Recoverable Nanocatalysts
2011 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Adjuvant Intraoperative Photodynamic Therapy in Head and Neck Cancer
2013
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
2012
Dye Sensitizers for Photodynamic Therapy
2013
Evaluation of a Novel Solubilized Formulation of Ibuprofen in the Treatment of Migraine Headache: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study
2000
Synthesis and Biological Evaluation of Folate Receptor-Targeted Boronated PAMAM Dendrimers as Potential Agents for Neutron Capture Therapy
2002
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
2000
Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors.
1997
Dendrimers in Oncology: An Expanding Horizon
2008
Charge‐Compensated Metallacarborane Building Blocks for Conjugation with Peptides
2015
Advance in Photosensitizers and Light Delivery for Photodynamic Therapy
2013
Signal Transduction through MAP Kinase Cascades
1998 Standout
Unraveling the Photoswitching Mechanism in Donor–Acceptor Stenhouse Adducts
2016 StandoutNobel
Selective boron drug delivery to brain tumors for boron neutron capture therapy
1997
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Works of Robert A. Fenstermaker being referenced
Tandem duplication of the epidermal growth factor receptor tyrosine kinase and calcium internalization domains in A-172 glioma cells
1998
2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy
2001
Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma
2014
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent
2004
Deletion and tandem duplication of exons 2–7 in the epidermal growth factor receptor gene of a human malignant glioma
2000
Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas
2004
Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function
2000
The impact of age and gender on the incidence of glial tumors in New York state from 1976–1995
2000
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors
2009
Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506
1998
Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model
2004
Neurosarcoidosis presenting as a large suprasellar mass
1998
Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy
2007
Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report
1998
Different Combinations of Regulatory Elements may Explain Why Placenta-Specific Expression of the Glycoprotein Hormone α-Subunit Gene Occurs Only in Primates and Horses1
1991
Molecular Targeting and Treatment of an Epidermal Growth Factor Receptor–Positive Glioma Using Boronated Cetuximab
2007
Abstract 1551: Targeting myeloid derived suppressor cells as novel strategy to enhance immunotherapy in murine prostate cancer models
2012
Platelet-derived growth factor A-chain gene transcription is mediated by positive and negative regulatory regions in the promoter
1994
Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin
1998
Development of a Syngeneic Rat Brain Tumor Model Expressing EGFRvIII and Its Use for Molecular Targeting Studies with Monoclonal Antibody L8A4
2005
Spinal Cord Trauma (Handbook of Clinical Neurology, Vol. 61, Revised Series 17)
1994
Molecular Targeting and Treatment of EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibody L8A4
2006
Molecular Targeting and Treatment of Composite EGFR and EGFRvIII-Positive Gliomas Using Boronated Monoclonal Antibodies
2008
Radiolabeling of Epidermal Growth Factor with 99mTc and in Vivo Localization following Intracerebral Injection into Normal and Glioma-Bearing Rats
1997
Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
2002
Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy
2003
Expression of the glycoprotein hormone alpha-subunit gene in the placenta requires a functional cyclic AMP response element, whereas a different cis-acting element mediates pituitary-specific expression.
1989
Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
1987
Transcriptional control of the platelet-derived growth factor subunit genes.
1993
Boronated Epidermal Growth Factor as a Potential Targeting Agent for Boron Neutron Capture Therapy of Brain Tumors
1996
The effect of epidermal growth factor receptor (EGFR) expression on in vivo growth of rat C6 glioma cells.
1995
Abstract 4746: Modulation of suppressive myeloid populations by tasquinimod.
2013
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy
2001
<title>Clinical studies of photodynamic therapy for malignant brain tumors: Karnofsky score and neurological score in patients with recurrent gloms treated with Photofrin PDT</title>
2002
Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
2002
Expression of the Glycoprotein Hormone a-Subunit Gene in the Placenta Requires a Functional Cyclic AMP Response Element, whereas a Different cis-Acting Element Mediates Pituitary-Specific Expression
1989
A cationic region of the platelet-derived growth factor (PDGF) A-chain (Arg159-Lys160-Lys161) is required for receptor binding and mitogenic activity of the PDGF-AA homodimer
1993